Author

Matthias Pinter 1

1 Medical University of Vienna,Vienna,Austria

CLINICAL SIGNIFICANCE OF SUBSTANTIALLY ELEVATED VON WILLEBRAND FACTOR ANTIGEN LEVELS IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

Katharina Pomej, Bernhard Scheiner, Lorenz Balcar, Rosa Johanna Nussbaumer, Johanna Weinzierl, Rafael Paternostro, Benedikt Simbrunner, Lukas Hartl, Mathias Jachs, David Bauer, Georg Semmler, Albert Friedrich Stättermayer, Matthias Pinter, Michael Trauner, Peter Quehenberger, Thomas Reiberger, Mattias Mandorfer

DIRECT ORAL ANTICOAGULANTS (DOACS) FOR OFF-LABEL USE IN PATIENTS WITH BUDD CHIARI SYNDROME (BCS)

Georg Semmler, Katharina Pomej, David Bauer, Benedikt Hofer, Lorenz Balcar, Benedikt Simbrunner, Matthias Pinter, Michael Trauner, Thomas Reiberger, Mattias Mandorfer, Bernhard Scheiner

FACTOR VIII/PROTEIN C RATIO INDEPENDENTLY PREDICTS LIVER-RELATED EVENTS BUT DOES NOT REFLECT THE HYPERCOAGULABLE STATE IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

Rosa Johanna Nussbaumer, Lorenz Balcar, Bernhard Scheiner, Johanna Weinzierl, Lukas Hartl, Mathias Jachs, David Bauer, Albert Friedrich Stättermayer, Matthias Pinter, Peter Quehenberger, Ton Lisman, Georg Semmler, Thomas Reiberger, Rafael Paternostro, Michael Trauner, Mattias Mandorfer, Benedikt Simbrunner

HIGH ALPHA-FETOPROTEIN LEVELS AND PRESENCE OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION CAN PREDICT THE OCCURRENCE OF HEPATOCELULLAR CARCINOMA IN CIRRHOTIC PATIENS

Simona Bota, Florian Hucke, Matthias Pinter, Mattias Mandorfer, Thomas Reiberger, Arnulf Ferlitsch, Michael Trauner, Wolfgang Sieghart, Markus Peck-Radosavljevic

LIMITED DIAGNOSTIC PERFORMANCE OF CONTROLLED ATTENUATION PARAMETER FOR ASSESSING HEPATIC STEATOSIS IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE AND PORTAL HYPERTENSION

Georg Semmler, Judith Stift, Bernhard Scheiner, Rafael Paternostro, Philipp Schwabl, Matthias Pinter, Katharina Wöran, Albert Friedrich Stättermayer, Michael Trauner, Thomas Reiberger, Mattias Mandorfer

SAFETY OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WITH ADVANCED LIVER DISEASE

Georg Semmler, David Bauer, Teresa Binter, Katharina Pomej, Lukas Hartl, Lorenz Balcar, Benedikt Simbrunner, Jeannette Becker, Matthias Pinter, Peter Quehenberger, Ton Lisman, Michael Trauner, Mattias Mandorfer, Bernhard Scheiner, Thomas Reiberger

THE SYSTEMIC INFLAMMATORY RESPONSE IDENTIFIES PATIENTS WITH ADVERSE CLINICAL OUTCOME FROM IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA

Matthias Pinter, Ambreen Muhammed, Sirish Sirish Dharmapuri, Tomi Jun, Thomas Marron, Celina Ang, Mahvish Muzaffar, Anushi Bulumulle, Musharraf Navaid, Hannah Hildebrand, Anwaar Saeed, Abdul Rafeh Naqash, Anuhya Gampa, Anjana Pillai, Yinghong Wang, Uqba Khan, Pei-Chang Lee, Yi-Hsiang Huang, Lorenz Balcar, Bernhard Schein

TRANSJUGULAR LIVER BIOPSY PERFORMED BY HEPATOLOGISTS TRAINED IN HEPATIC VENOUS PRESSURE GRADIENT MEASUREMENTS IS SAFE AND PROVIDES IMPORTANT DIAGNOSTIC AND PROGNOSTIC INFORMATION

Georg Semmler, Judith Stift, Cita Walzel, Mattias Mandorfer, Rémy Schwarzer, Philipp Schwabl, Rafael Paternostro, Bernhard Scheiner, Katharina Wöran, Matthias Pinter, Albert Friedrich Stättermayer, Michael Trauner, Markus Peck-Radosavljevic, Arnulf Ferlitsch, Thomas Reiberger

VON WILLEBRAND FACTOR FOR OUTCOME PREDICTION WITHIN DIFFERENT CLINICAL STAGES OF ADVANCED CHRONIC LIVER DISEASE

Rafael Paternostro, Bernhard Scheiner, Lorenz Balcar, Lukas Hartl, Mathias Jachs, David Bauer, Georg Semmler, Albert Friedrich Stättermayer, Matthias Pinter, Peter Quehenberger, Michael Trauner, Thomas Reiberger, Mattias Mandorfer, Benedikt Simbrunner

Item 1 - 9 / 10
1